|
Anticoagulant mechanisms
Citations 11-20 of 73 total displayed.
|
Past content
(since Jan 1999):
|
- Corrections
Correction
-
Circulation 2006;113:e695, doi:10.1161/CIRCULATIONAHA.106.174785
[Full text]
- Editorials
Oral Anticoagulation for Atrial Fibrillation After ST-Elevation Myocardial Infarction: New Evidence to Guide Clinical Practice
- Frederick G. Kushner and Elliott M. Antman
Circulation 2005;112:3212-3214, doi:10.1161/CIRCULATIONAHA.105.579862
[Full text]
- Basic Science for Clinicians
Molecular Regulation of Platelet-Dependent Thrombosis
- Jane E. Freedman
Circulation 2005;112:2725-2734, doi:10.1161/CIRCULATIONAHA.104.494468
[Abstract]
[Full text]
- Editorials
Use of Heart Valves in Older Patients
- Lawrence H. Cohn
Circulation 2005;111:2152-2153, doi:10.1161/01.CIR.0000165305.02689.86
[Full text]
- Interventional Cardiology
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial
- Shamir R. Mehta, Philippe Gabriel Steg, Christopher B. Granger, Jean-Pierre Bassand, David P. Faxon, Jeffrey I. Weitz, Rizwan Afzal, Bonnie Rush, Ron J.G. Peters, Madhu K. Natarajan, James L. Velianou, David M. Goodhart, Marino Labinaz, Jean-Francois Tanguay, Keith A.A. Fox, Salim Yusuf for the ASPIRE Investigators
Circulation 2005;111:1390-1397, doi:10.1161/01.CIR.0000158485.70761.67
[Abstract]
[Full text]
- Molecular Cardiology
Role for the Kunitz-3 Domain of Tissue Factor Pathway Inhibitor- in Cell Surface Binding
- Orlando Piro and George J. Broze, Jr
Circulation 2004;110:3567-3572; published online before print as doi:10.1161/01.CIR.0000148778.76917.89
[Abstract]
[Full text]
- Articles
Role for the Kunitz-3 Domain of Tissue Factor Pathway Inhibitor- in Cell Surface Binding
- Orlando Piro and George J. Broze, Jr.
Circulation published November 22, 2004, doi:10.1161/01.CIR.0000148778.76917.89
[Abstract]
- AHA Scientific Statements
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
- Jane W. Newburger, Masato Takahashi, Michael A. Gerber, Michael H. Gewitz, Lloyd Y. Tani, Jane C. Burns, Stanford T. Shulman, Ann F. Bolger, Patricia Ferrieri, Robert S. Baltimore, Walter R. Wilson, Larry M. Baddour, Matthew E. Levison, Thomas J. Pallasch, Donald A. Falace, and Kathryn A. Taubert
Circulation 2004;110:2747-2771, doi:10.1161/01.CIR.0000145143.19711.78
[Abstract]
[Full text]
- Vascular Medicine
Homozygous Deficiency of Heparin Cofactor II: Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis
- Javier Corral, Justo Aznar, Rocio Gonzalez-Conejero, Piedad Villa, Antonia Miñano, Amparo Vayá, Robin W. Carrell, James A. Huntington, and Vicente Vicente
Circulation 2004;110:1303-1307; published online before print as doi:10.1161/01.CIR.0000140763.51679.D9
[Abstract]
[Full text]
- Articles
Homozygous Deficiency of Heparin Cofactor II. Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis
- Javier Corral, Justo Aznar, Rocio Gonzalez-Conejero, Piedad Villa, Antonia Miñano, Amparo Vayá, Robin W. Carrell, James A. Huntington, and Vicente Vicente
Circulation published August 30, 2004, doi:10.1161/01.CIR.0000140763.51679.D9
[Abstract]
|
|
